InvestorsHub Logo
Followers 8
Posts 1480
Boards Moderated 0
Alias Born 05/01/2010

Re: drkazmd65 post# 131432

Monday, 04/24/2017 1:43:44 PM

Monday, April 24, 2017 1:43:44 PM

Post# of 146211
DRKAZMD65 IS 100% CORRECT

The Altman Z-score cannot take into account facts specific to NNVC like what would happen if they go their drug to clinical testing.


This is, at the same time, a weakness and a strength. It is a weakness just as DrKAZMD65 points out. Yet this can be a strength because prevents getting caught up in details that may weigh heavily on our decision but are unhelpful in a predictive sense.

If NNVC can get their med to clinical testing I would agree the stock will zoom up. But failing that, going only from the financials there is a high probability of bankruptcy according to Altman's model.

The bulls will continue to believe their story and the bears will continue to believe theirs. And so it goes.

Your posts are always appreciated DRKAZMD65

Trendliner
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News